• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌发生过程中p53表达的临床病理特征及时间顺序

Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer.

作者信息

Karim Sajjad, Mirza Zeenat, Naseer Muhammad Imran, Al-Qahtani Mohammed Hussain, Ali Arif

出版信息

Hepatogastroenterology. 2013 Nov-Dec;60(128):2113-8.

PMID:24719956
Abstract

BACKGROUND/AIMS: The present study was aimed to investigate the correlation between selected clinicopathological characteristics and p53 protein overexpression, in Indian gastric cancer patients.

METHODOLOGY

Here, we studied specimens from 103 patients with gastric carcinomas and cases were categorized by AJCC-TNM classification. The p53 expression was analyzed in all the specimens by immunohistochemistry (IHC) and was correlated with the clinicopathological characteristics of the patients as well as etiological factors for gastric cancer. The cases were considered p53 overexpressed if more than 25% of the tumor cells were found to be expressing this protein.

RESULTS

We found significant association of p53 overexpression with the gender (p = 0.004) and histology grades (p = 0.001). However, p53 overexpression was not found to be significantly associated with other clinicopathological characteristics like age, cell differentiation, stage and location and various etiological factors.

CONCLUSIONS

Our observation showed that IHC-based detection of altered expression of p53 protein in gastric carcinomas may play an important role for diagnosing the progression of gastric carcinoma, even in the early stages.

摘要

背景/目的:本研究旨在调查印度胃癌患者特定临床病理特征与p53蛋白过表达之间的相关性。

方法

在此,我们研究了103例胃癌患者的标本,并根据AJCC-TNM分类对病例进行了分类。通过免疫组织化学(IHC)分析所有标本中的p53表达,并将其与患者的临床病理特征以及胃癌的病因因素相关联。如果发现超过25%的肿瘤细胞表达该蛋白,则认为病例存在p53过表达。

结果

我们发现p53过表达与性别(p = 0.004)和组织学分级(p = 0.001)之间存在显著关联。然而,未发现p53过表达与年龄、细胞分化、分期和位置等其他临床病理特征以及各种病因因素有显著关联。

结论

我们的观察表明,基于免疫组织化学检测胃癌中p53蛋白表达改变可能对诊断胃癌进展,甚至早期胃癌进展发挥重要作用。

相似文献

1
Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer.胃癌发生过程中p53表达的临床病理特征及时间顺序
Hepatogastroenterology. 2013 Nov-Dec;60(128):2113-8.
2
Biological prognostic parameters in gastric carcinomas.胃癌的生物学预后参数。
Chirurgia (Bucur). 2014 May-Jun;109(3):347-54.
3
Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.p53和c-erbB-2表达与胃癌组织病理学特征、幽门螺杆菌感染及预后的关系
Hepatogastroenterology. 1997 Mar-Apr;44(14):604-9.
4
The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.胃癌中p53蛋白的免疫组化表达。与临床病理因素及患者生存率的相关性。
Rom J Morphol Embryol. 2010;51(2):249-57.
5
Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.分化型微小胃癌,特别关注肿瘤发生过程中肠化生、增殖带和p53蛋白的意义。
Cancer. 1999 Apr 15;85(8):1719-29.
6
Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.p53的过表达与进展期胃癌的生长模式及预后相关。
Hepatogastroenterology. 1997 Mar-Apr;44(14):546-53.
7
The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.p53/拓扑异构酶 I 和 p53/拓扑异构酶 IIalpha 免疫表型与卵巢癌进展的关系。
Adv Clin Exp Med. 2012 Jan-Feb;21(1):35-42.
8
The clinical significance of p53 accumulation in gastric carcinoma.p53蛋白在胃癌中积累的临床意义
Cancer. 1996 May 15;77(10):2005-12. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2005::AID-CNCR7>3.0.CO;2-P.
9
Overexpression of p53 protein in gallbladder carcinoma in North India.
Eur J Surg Oncol. 2000 Mar;26(2):164-7. doi: 10.1053/ejso.1999.0763.
10
Immunohistochemical HER2 expression not associated with clinicopathological characteristics of stage I-III gastric cancer patients.免疫组化HER2表达与I-III期胃癌患者的临床病理特征无关。
Hepatogastroenterology. 2014 Sep;61(134):1817-21.

引用本文的文献

1
IL-6 and miR-1271 expression levels in elderly and young gastric cancer patients and correlation analysis with prognosis.老年和青年胃癌患者中白细胞介素-6和微小RNA-1271的表达水平及其与预后的相关性分析
Oncol Lett. 2019 Jun;17(6):5419-5424. doi: 10.3892/ol.2019.10230. Epub 2019 Apr 9.
2
Molecular alterations in gastric cancer with special reference to the early-onset subtype.胃癌的分子改变,特别涉及早发型亚型。
World J Gastroenterol. 2016 Feb 28;22(8):2460-74. doi: 10.3748/wjg.v22.i8.2460.
3
Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors.
对肿瘤细胞对组蛋白去乙酰化酶抑制剂的选择性凋亡反应的时间序列基因表达数据的系统分析。
Comput Math Methods Med. 2014;2014:867289. doi: 10.1155/2014/867289. Epub 2014 Oct 13.